Bacteriological assessment of clindamycin, a new lincomycin derivative.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D013293:Enterococcus faecalis / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D006027:Glycosides / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects; D008034:Lincomycin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D011759:Pyrrolidines / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines; D004917:Erythromycin; D008034:Lincomycin; D010400:Penicillin G; D010068:Oxacillin